“aduro-biotech” Archives

in
Entry Author Date Location
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs 01/30/19 San Francisco
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic 03/28/18 San Francisco
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy 02/27/17 New York
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound 05/16/16 San Francisco
Aduro Lands New Berkeley Life Sciences Digs, with Room to Grow 09/18/15 San Francisco
West Coast Biotech Roundup: CRISPR, Doudna, Aduro, Amgen, NEA & More 04/16/15 San Francisco
Aduro BioTech Obtains $119,000,000 New Funding 04/15/15 San Francisco
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More 04/02/15 San Diego
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
Aduro BioTech Garners $55,000,000 Series C Funding Round 06/12/14 San Francisco
Aduro BioTech Secures $6,500,000 New Financing 01/31/13 San Francisco
Aduro BioTech Secures $19,250,000 Series B Funding Round 04/20/11 San Francisco
Page 1 of 1

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.